J.P. Morgan Weighs in on Juno Therapeutics Inc (JUNO) and Celgene Corporation (CELG) Following Partnership Announcement
On June 29, Juno Therapeutics Inc (NASDAQ:JUNO) and Celgene Corporation (NASDAQ:CELG) announced a ten-year collaboration to develop new therapies for cancer and auto-immune diseases, specifically T cell therapies. Celgene will have the option to commercialize Juno’s programs outside North America, while Juno will be have the ability to co-develop and co-promote certain Celgene therapies. CAR … Read more